Filing Details
- Accession Number:
- 0001181431-10-027642
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-05-18 13:00:00
- Reporting Period:
- 2010-05-14
- Filing Date:
- 2010-05-18
- Accepted Time:
- 2010-05-18 16:15:14
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 820096 | Perrigo Co | PRGO | Pharmaceutical Preparations (2834) | 382799573 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1398337 | Louis Yu | C/O Perrigo Company 515 Eastern Avenue Allegan MI 49010 | Senior Vp Global Quality | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2010-05-14 | 3,330 | $20.50 | 4,195 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2010-05-14 | 3,330 | $61.12 | 865 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option Right to Buy | Disposition | 2010-05-14 | 1,665 | $0.00 | 1,665 | $20.50 |
| Common Stock | Employee Stock Option Right to Buy | Disposition | 2010-05-14 | 1,665 | $0.00 | 1,665 | $20.50 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2008-08-30 | 2017-08-30 | No | 4 | M | Direct |
| 0 | 2009-08-30 | 2017-08-30 | No | 4 | M | Direct |
Footnotes
- The price in column 4 is a weighted average. The prices actually received ranged from $61.105 to $61.145. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each seperate price within the range.
Billionaire Hedge Funds
